IPO · Nov 2026 · United States
vVARDIS Holding AG: initial public offering (SEC 424B4 prospectus)Official filing: 424B4 of vVARDIS Holding AG · Counsel to the underwriters (U.S. federal) · with Davis Polk & Wardwell LLP
Covington & Burling LLP is a law firm in Germany, with 1,500 professionals and 137 profiles on its own site.

How Covington & Burling LLP is organised, read from the titles and practice areas it publishes for each lawyer. A head is named only where the firm states one; otherwise the partner admitted earliest on record stands first and is labelled so.
Managing Partner
89 of Covington & Burling LLP’s profiles print the firm’s whole practice list rather than the person’s own, so they are left out of the groups above; only titles the firm states are shown.
Deals and matters Covington & Burling LLP is named on, as headlined by the legal press or by the firm on its own site. Each links to its source.
IPO · Nov 2026 · United States
vVARDIS Holding AG: initial public offering (SEC 424B4 prospectus)Official filing: 424B4 of vVARDIS Holding AG · Counsel to the underwriters (U.S. federal) · with Davis Polk & Wardwell LLP
M&A · Nov 2026 · Germany
Covington Represents Trustmark in $3.2B Merger with Hancock WhitneyCovington & Burling LLP's own site · Counsel to Trustmark
M&A · Nov 2026 · Germany
Covington Advises Shield on $5.3B Echodyne AcquisitionCovington & Burling LLP's own site · Counsel to Shield
M&A · Oct 2026 · Germany
Covington Advises Salesforce on Acquisition of Rune TechnologiesCovington & Burling LLP's own site · Counsel to Salesforce
Financing · Oct 2026 · Germany
Covington Advises Sibelco on Letter of Intent with U.S. Department of Commerce for Up to $56 Million in CHIPS Act FundingCovington & Burling LLP's own site · Counsel to Sibelco
M&A · Oct 2026 · Germany
Covington Represents Gilead in Acquisition of Oral IL-23R Inhibitor Program from PepStar TherapeuticsCovington & Burling LLP's own site · Counsel to Gilead
deal · Nov 2026
Covington Represents Trustmark in $3.2B Merger with Hancock WhitneyNames North America
deal · Nov 2026
Covington Advises Shield on $5.3B Echodyne AcquisitionNames North America
award · Nov 2026
Covington Once Again Ranks First in Law.com’s UK Pro Bono Rankingsdeal · Oct 2026
Covington Advises Salesforce on Acquisition of Rune Technologiesdeal · Oct 2026
Covington Advises Sibelco on Letter of Intent with U.S. Department of Commerce for Up to $56 Million in CHIPS Act FundingNames North America
deal · Oct 2026
Covington Represents Gilead in Acquisition of Oral IL-23R Inhibitor Program from PepStar Therapeutics